WASHINGTON - Eligible Medicare beneficiaries can now obtain certain anti-obesity medications for $50 a month under a new ...

Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...

Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.

A new CMS pilot gives seniors $50 access to GLP-1 drugs like Wegovy, potentially reshaping food demand, nutrition strategies ...

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

The Medicare GLP-1 Bridge Program has opened and will remain open through 2027, giving some Medicare beneficiaries greater ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as Medicare offers coverage for GLP-1 weight-loss drugs for ...

Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.

The Centers for Medicare & Medicaid Services launched the Medicare GLP-1 Bridge program, an initiative designed to test the impact of increased access to GLP-1 drugs for weight management among ...

A Medicare pilot program could expand access to GLP-1 weight-loss drugs for millions of seniors while lowering monthly costs ...

The Centers for Medicare & Medicaid Services July 1 launched the Medicare GLP-1 Bridge, a short-term demonstration program designed to provide eligible Medicare Part D beneficiaries with access to ...